Earnings from continuing operations at Swiss pharmaceutical firm Novartis grew from last year, the firm revealed in results ...

Q4 2024 Management View CEO Topi Manner highlighted the strong revenue growth of 2.9% in Q4 2024, the best quarterly growth of the year, driven by International Digital Services (IDS) and mobile ...

Roche has reported a 7% increase in full-year 2024 sales at constant exchange rates (CER), reaching CHF 60.5bn ($66.9bn). The ...

AbbVie’s ABBV 2024 revenue grew 4.6% on a constant currency basis, with 2025 guidance of 5.7% growth and new 2027 guidance for combined sales of immunology drug Skyrizi and Rinvoq of $31 billion (up ...